Furthermore, elevated LYRM2 levels were correlated with more advanced tumour grade (Figure 1G) and tumour stage (Figure 1H) in HCC patients, based on the data mining in TCGA database. The gene discussed is LYRM2; the disease is hepatocellular carcinoma.